# Kefir Gut Microbiome Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/kefir-gut-microbiome-randomized-trial-evidence-review
Category: evidence-review
Summary: Kefir Gut Microbiome Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are s
Last reviewed: 2026-06-26
Reviewed by: Migaku Evidence Review
# Kefir Gut Microbiome Randomized Trial: What the Evidence Says

## Quick Answer

Kefir Gut Microbiome Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Kefir: A Potential Gut Microbiota Modulator: A Systematic Review of Human Interventional Studies. | systematic review | 1 | 2026-06-01 | 10.1002/mbo3.70297 |
| Dairy Bioactive Compounds as Precision Modulators of Gut Microbiota: From Molecular Mechanisms to Personalized Immunometabolic Health | narrative review | 3 | 2026-06-04 | 10.3390/foods15112024 |

## What The Sources Report

- The risk of bias was assessed using Cochrane risk-of-bias tool and Risk of bias of non-randomized trials. [Hamsho M (2026); evidence level 1]
- Kefir-specific bacterial species and strains were found in participants fecal samples suggesting colonization properties. [Hamsho M (2026); evidence level 1]
- There is strong evidence of a correlation linking gut dysbiosis with reduced microbial diversity and a disruption in the balance of microbial communities, and inflammatory and metabolic disorders, including obesity and type 2 diabetes mellitus (T2DM). [Alhaj Omar A. (2026); evidence level 3]
- Meta-analyses of clinical interventions corroborate the results of regular yogurt or kefir intake, showing significant decreases in fasting glucose, low-density lipoprotein (LDL) cholesterol, and systemic C-reactive protein (CRP) in dysbiosis-associated conditions, with effect sizes dependent on strain composition, dose, and host genotype. [Alhaj Omar A. (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For kefir gut microbiome randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Hamsho M (2026). Kefir: A Potential Gut Microbiota Modulator: A Systematic Review of Human Interventional Studies.. DOI: 10.1002/mbo3.70297. PMCID: PMC13111804. PMID: 42036973. https://pmc.ncbi.nlm.nih.gov/articles/PMC13111804/
- Alhaj Omar A. (2026). Dairy Bioactive Compounds as Precision Modulators of Gut Microbiota: From Molecular Mechanisms to Personalized Immunometabolic Health. DOI: 10.3390/foods15112024. PMCID: PMC13256291. PMID: 42279810. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13256291/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.